207 related articles for article (PubMed ID: 11063957)
1. Abnormalities of coagulation in hypertensive patients with reduced creatinine clearance.
Catena C; Zingaro L; Casaccio D; Sechi LA
Am J Med; 2000 Nov; 109(7):556-61. PubMed ID: 11063957
[TBL] [Abstract][Full Text] [Related]
2. Relationship of lipoprotein(a) to variables of coagulation in hypertensive subjects.
Sechi LA; De Marchi S
J Investig Med; 2001 Jan; 49(1):12-20. PubMed ID: 11217142
[TBL] [Abstract][Full Text] [Related]
3. Increased fibrinogen levels and hemostatic abnormalities in patients with arteriolar nephrosclerosis: association with cardiovascular events.
Sechi LA; Zingaro L; Catena C; De Marchi S
Thromb Haemost; 2000 Oct; 84(4):565-70. PubMed ID: 11057851
[TBL] [Abstract][Full Text] [Related]
4. Lipoprotein (a), haemostatic variables and cardiovascular damage in hypertensive patients.
Sechi LA; Catena C; Casaccio D; Zingaro L
J Hypertens; 2000 Jun; 18(6):709-16. PubMed ID: 10872555
[TBL] [Abstract][Full Text] [Related]
5. Relationship of fibrinogen levels and hemostatic abnormalities with organ damage in hypertension.
Sechi LA; Zingaro L; Catena C; Casaccio D; De Marchi S
Hypertension; 2000 Dec; 36(6):978-85. PubMed ID: 11116111
[TBL] [Abstract][Full Text] [Related]
6. Activation of the extrinsic coagulation pathway in patients with severe sepsis and septic shock.
Gando S; Nanzaki S; Sasaki S; Aoi K; Kemmotsu O
Crit Care Med; 1998 Dec; 26(12):2005-9. PubMed ID: 9875912
[TBL] [Abstract][Full Text] [Related]
7. Early decrease in coagulation activity after myocardial infarction is associated with lower risk of new ischaemic events: observations from the ESTEEM Trial.
Christersson C; Oldgren J; Bylock A; Siegbahn A; Wallentin L
Eur Heart J; 2007 Mar; 28(6):692-8. PubMed ID: 17314111
[TBL] [Abstract][Full Text] [Related]
8. Coagulation system activated in Duchenne muscular dystrophy patients with cardiac dysfunction.
Saito T; Yamamoto Y; Matsumura T; Nozaki S; Fujimura H; Shinno S
Brain Dev; 2005 Sep; 27(6):415-8. PubMed ID: 16122628
[TBL] [Abstract][Full Text] [Related]
9. Blood coagulation parameters in retinal arterial occlusion.
Sagripanti A; Romani A; Ferretti A; Ragone MC; Baicchi U; Carpi A; Nardi M
Graefes Arch Clin Exp Ophthalmol; 1999 Jun; 237(6):480-3. PubMed ID: 10379608
[TBL] [Abstract][Full Text] [Related]
10. Coagulation activation in patients with Binswanger disease.
Tomimoto H; Akiguchi I; Wakita H; Osaki A; Hayashi M; Yamamoto Y
Arch Neurol; 1999 Sep; 56(9):1104-8. PubMed ID: 10488811
[TBL] [Abstract][Full Text] [Related]
11. Hemostatic abnormalities may predict chronic hypertension after preeclampsia.
Bremme K; Blombäck M
Gynecol Obstet Invest; 1996; 41(1):20-6. PubMed ID: 8821879
[TBL] [Abstract][Full Text] [Related]
12. Association of a prothrombotic state with left-ventricular diastolic dysfunction in hypertension: a tissue-Doppler imaging study.
Catena C; Colussi G; Fedrizzi S; Sechi LA
J Hypertens; 2013 Oct; 31(10):2077-84. PubMed ID: 24107736
[TBL] [Abstract][Full Text] [Related]
13. Coagulation and fibrinolytic markers in a two-month follow-up of coronary bypass surgery.
Parolari A; Colli S; Mussoni L; Eligini S; Naliato M; Wang X; Gandini S; Tremoli E; Biglioli P; Alamanni F
J Thorac Cardiovasc Surg; 2003 Feb; 125(2):336-43. PubMed ID: 12579103
[TBL] [Abstract][Full Text] [Related]
14. Intrarenal Vascular Resistance is Associated With a Prothrombotic State in Hypertensive Patients.
Catena C; Colussi G; Novello M; Fagotto V; Sechi LA
Kidney Blood Press Res; 2016; 41(6):929-936. PubMed ID: 27894116
[TBL] [Abstract][Full Text] [Related]
15. [D-dimer, thrombin-antithrombin III-complex (TAT) and prothrombin fragment 1+2 (PTF). Parameters for monitoring therapy with low molecular-weight heparin in coagulation disorders].
Hofmann M; Rest A; Hafner G; Tanner B; Brockerhoff P; Weilemann LS
Anaesthesist; 1997 Aug; 46(8):689-96. PubMed ID: 9382207
[TBL] [Abstract][Full Text] [Related]
16. Coagulation system and platelets are fully activated in uncomplicated sepsis.
Mavrommatis AC; Theodoridis T; Orfanidou A; Roussos C; Christopoulou-Kokkinou V; Zakynthinos S
Crit Care Med; 2000 Feb; 28(2):451-7. PubMed ID: 10708182
[TBL] [Abstract][Full Text] [Related]
17. Plasma levels of prothrombin fragment F1+2, D-dimer and prothrombin time correlate with clinical stage and lymph node metastasis in operable gastric cancer patients.
Kwon HC; Oh SY; Lee S; Kim SH; Han JY; Koh RY; Kim MC; Kim HJ
Jpn J Clin Oncol; 2008 Jan; 38(1):2-7. PubMed ID: 18258711
[TBL] [Abstract][Full Text] [Related]
18. A prothrombotic state is associated with early arterial damage in hypertensive patients.
Catena C; Colussi G; Brosolo G; Sechi LA
J Atheroscler Thromb; 2012; 19(5):471-8. PubMed ID: 22659531
[TBL] [Abstract][Full Text] [Related]
19. Prothrombin fragment 1.2 and modified antithrombin as predictors of disseminated intravascular coagulation and thrombotic risk in thermal injury.
Kowal-Vern A; Walenga JM; Hoppensteadt D; Gamelli RL
J Burn Care Res; 2013; 34(4):459-64. PubMed ID: 23202877
[TBL] [Abstract][Full Text] [Related]
20. Prothrombin fragment 1 + 2 and antithrombin III-thrombin complex in microalbuminuric type 2 diabetic patients.
Gruden G; Cavallo-Perin P; Romagnoli R; Olivetti C; Frezet D; Pagano G
Diabet Med; 1994 Jun; 11(5):485-8. PubMed ID: 8088128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
